DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 158 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | +13.8% | 10,000 | -0.2% | 0.01% | +16.7% |
| Q2 2023 | $130 | +32.7% | 10,025 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $98 | -8.4% | 10,025 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $107 | -99.9% | 10,025 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $105,000 | -46.2% | 10,025 | -35.4% | 0.01% | -40.0% |
| Q2 2022 | $195,000 | +16.1% | 15,525 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $168,000 | -22.9% | 15,525 | +0.2% | 0.01% | -20.0% |
| Q4 2021 | $218,000 | -9.2% | 15,500 | +24.0% | 0.01% | -9.1% |
| Q3 2021 | $240,000 | +95.1% | 12,500 | 0.0% | 0.01% | +120.0% |
| Q2 2021 | $123,000 | +48.2% | 12,500 | -13.8% | 0.01% | +25.0% |
| Q4 2019 | $83,000 | +59.6% | 14,500 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $52,000 | – | 14,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |